You searched for - Cancure

About
Cancer
- Current Treatments
- Market
Therapies
Investors
Contact

New Search

If you are not happy with the results below please do another search

News

NousCom receives $49M to trial off-the-shelf cancer vaccine November 9, 2017
AstraZeneca bolts Incyte’s IDO1 immunomodulator to its lung cancer plans November 1, 2017
Incyte pays MacroGenics $150M for PD-1 inhibitor October 26, 2017
Gilead buys CAR-T developer Kite Pharma for $12B August 29, 2017

Contact

Mr Craig Miles
craig@cancure.com
+61 (0) 408 778 797
PO Box 1177, Broadbeach,
Queensland, Australia 4218

Copyright © 2015 All rights reserved.

Scroll to top